Chromium
Chromium has been studied in 59 papers since 1992: 2 trials and 48 observational studies in people, 1 in cells, 8 reviews; 25 in the past year. The newest paper, Nov 10, 2026: “Associations of serum lead, antimony, chromium, and cobalt with hypertension prevalence among lead-exposed workers: a multi-metal cross-sectional study in Xinjiang, China”.
6 new papers in 30 daysSee all 105 papers on chromium
At a glance
Independent labs found the same change in people. 13 independent labs in 6 countries; 4 trials, none about aging, 2 with no results posted.
“The present results indicate that Cr supplementation does not improve glucose tolerance or serum lipid levels in elderly subjects with stable impaired glucose tolerance.”
1 of its findings points the other way.
- 13 independent labs in 6 countries
- 1 finding against
- 4 trials, none about aging, 2 with no results posted
- Funders: National Natural Science Foundation of China and others
- Human trial2
- Humans48
- Cells1
Studies in people
1 study gave chromium to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on glucose tolerance no change: Has no effect on serum lipids | Randomized trial6 months | 26 people65–74 yearsOlder adults; stable impaired glucose tolerance | The British journal of nutrition, Jul 1, 1992 |
What did studies of chromium find?
6Studies of chromium measured 6 outcomes, among them type 2 diabetes, biological age and estimated glomerular filtration rate.
Type 2 diabetes
no changein humans1
1 study
Type 2 diabetes
no changein humans1
Chromium was not clearly linked with type 2 diabetes in humans (FTO rs9939609 AA/AT genotypes).
“No significant association was observed among women carrying the AA/AT genotypes.”
HumansFTO rs9939609 AA/AT genotypesdietary intakefemales
Scientific reports
Biological age
upin humans1
1 study
Biological age
upin humans1
Chromium is linked with higher biological age in schizophrenia patients (1.029, 95 % CI: 0.303-1.756).
“chromium (1.029, 95 % CI: 0.303-1.756)”
Humansin schizophrenia patientsn = 104
Journal of hazardous materials
Estimated glomerular filtration rate
no changein humans1
1 study
Estimated glomerular filtration rate
no changein humans1
Chromium was not clearly linked with estimated glomerular filtration rate in humans (Percent change = 0.06 %; 95 % CI, -0.80 %, 0.95 %).
“we did not find significant association between urinary chromium and eGFR (Percent change = 0.06 %; 95 % CI, -0.80 %, 0.95 %).”
Humansn = 183
Ecotoxicology and environmental safety
Urinary albumin-to-creatinine ratio
upin humans1
1 study
Urinary albumin-to-creatinine ratio
upin humans1
Chromium is linked with higher urinary albumin-to-creatinine ratio in humans (Percent change = 10.16 %; 95 % CI, 6.41 %, 14.06 %).
“Urinary chromium was associated with CKD (odds ratio [OR] = 1.29; 95 % confidence interval [CI], 6.41, 14.06) and UACR (Percent change = 10.16 %; 95 % CI, 6.41 %, 14.06 %)”
Humansn = 183
Ecotoxicology and environmental safety
Serum lipids
no changein humans1
1 study
Serum lipids
no changein humans1
Chromium showed no clear effect on serum lipids in humans (stable impaired glucose tolerance).
“The present results indicate that Cr supplementation does not improve glucose tolerance or serum lipid levels in elderly subjects with stable impaired glucose tolerance.”
Human trialstable impaired glucose tolerancechromium-rich yeast160 micrograms Cr/d6 monthsn = 26
The British journal of nutrition
Glucose tolerance
no changein humans1
1 study
Glucose tolerance
no changein humans1
Chromium showed no clear effect on glucose tolerance in humans (stable impaired glucose tolerance).
“The present results indicate that Cr supplementation does not improve glucose tolerance or serum lipid levels in elderly subjects with stable impaired glucose tolerance.”
Human trialstable impaired glucose tolerancechromium-rich yeast160 micrograms Cr/d6 monthsn = 26
The British journal of nutrition
What is chromium linked with?
15Studies link chromium with 15 measures, among them chronic kidney disease, hypertension prevalence and early or premature menopause.
Chronic kidney disease
upin humans2OR 1.29
2 studies
Chronic kidney disease
upin humans2OR 1.29
Chromium is associated with chronic kidney disease in humans (occupational multi-metal exposure).
“Li, Al, Cr, and Ni showed positive associations with CKD, whereas Zn and Se showed inverse associations.”
Humansoccupational multi-metal exposure
Toxics
Chromium is associated with chronic kidney disease in humans (OR = 1.29, 95% CI 6.41, 14.06).
“Urinary chromium was associated with CKD (odds ratio [OR] = 1.29; 95 % confidence interval [CI], 6.41, 14.06)”
Humansn = 183
Ecotoxicology and environmental safety
Hypertension prevalence
upin humans1OR 2.158
1 study
Hypertension prevalence
upin humans1OR 2.158
Chromium is associated with hypertension prevalence in humans (Lead-exposed workers in northwestern China) (OR 2.158, 95% CI 1.064–4.440).
“Specifically, lead, chromium, and antimony were significantly positively associated with hypertension prevalence, whereas cobalt was negatively associated with hypertension prevalence.”
HumansLead-exposed workers in northwestern Chinan = 419
Frontiers in public health
Early or premature menopause
downin humans1−50% lower likelihood
1 study
Early or premature menopause
downin humans1−50% lower likelihood
Chromium is associated with early or premature menopause in humans (50% lower likelihood).
“However, the likelihood of an early or premature menopause was 50% lower among women in the fourth quartile.”
Humansfourth quartile of chromium concentrationsfemales
International journal of environmental health research
Type 2 diabetes
downin humans1OR 0.984
1 study
Type 2 diabetes
downin humans1OR 0.984
Chromium is associated with type 2 diabetes in humans (FTO rs9939609 TT genotype; adjusted models) (OR = 0.984, 95% CI: 0.972–0.996; p = 0.010).
“Among women with the TT genotype, higher dietary chromium intake was significantly associated with lower odds of T2DM in all adjusted models”
HumansFTO rs9939609 TT genotype; adjusted modelsdietary intakefemales
Scientific reports
Breast cancer
upin humans1RR 1.07
1 study
Breast cancer
upin humans1RR 1.07
Chromium is linked with a higher risk of breast cancer in humans (residential exposure over a 10-year pre-diagnosis window) (adjusted RR 1.07, 95% CI: 1.05, 1.08).
“Exposure to PM2.5-bound chromium (adjusted RR 1.07, 95% CI: 1.05, 1.08)”
Humansresidential exposure over a 10-year pre-diagnosis window10-year pre-diagnosis windowfemales
Long-term exposure to PM2.5-bound metals and female breast cancer incidence in New Mexico, USA
Air quality, atmosphere, & health
Cardiovascular-kidney-metabolic syndrome
downin humans1
1 study
Cardiovascular-kidney-metabolic syndrome
downin humans1
Chromium is linked with a lower risk of cardiovascular-kidney-metabolic syndrome in humans (repeated-measures cohort).
“whereas Cr showed an inverse association (0.79, 0.60-0.97)”
Humansrepeated-measures cohortn = 472
Ecotoxicology and environmental safety
Brachial-ankle pulse wave velocity
downin humans1
1 study
Brachial-ankle pulse wave velocity
downin humans1
Chromium is associated with brachial-ankle pulse wave velocity in humans (β = -0.041).
“The generalized linear model (GLM) indicated that chromium (Cr) was negatively associated with baPWV (β = -0.041).”
Humansn = 431
BMC public health
Telomere length
upin humans1
1 study
Telomere length
upin humans1
Chromium is associated with telomere length in humans.
“In the elderly, Cr and Mn were significantly positively correlated with rTL”
Humans
Scientific reports
Cognitive impairment
upin humans1OR 2.15
1 study
Cognitive impairment
upin humans1OR 2.15
Chromium is linked with a higher risk of cognitive impairment in males (OR 2.15, 95% CI 1.27-3.63).
“Cr was positively associated with cognitive impairment in the male (OR 95 % CI = 2.15 (1.27, 3.63)) and 60- to 70-year-old (OR 95 % CI = 2.10 (1.24, 3.57)) groups”
Humansin malesmalesn = 1,068
The Science of the total environment
Diminished renal function
upin humans1
1 study
Diminished renal function
upin humans1
Chromium is associated with diminished renal function in humans (midlife and elderly community without kidney disease at baseline) (p < 0.05).
“Diminished renal function, as evaluated based on fast kidney function decline, or estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2, was positively associated with the plasma concentrations of chromium and potassium”
Humansmidlife and elderly community without kidney disease at baselineplasman = 1,368
Toxics
All 15Fewer
Has chromium been tested in people?
0 of 4 about agingYes: 2 trials and 48 observational studies in people have been published, and 4 trials are registered.
In trials
Phase 4Active, not recruiting1 trial
Phase 3Completed1 trial
Phase 2Completed1 trial
Phase 2Completed1 trial
Phase 2Completed1 trial
Phase 2Active, not recruiting1 trial
Trial sponsors
1 trialPhase 460 people
1 trialPhase 3240 people
1 trialPhase 2670 people
1 trialPhase 260 people
Funding
1 grant since 2019US Department of Veterans Affairs